Intervention

Olodaterol (BI 1744)

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions1
Lead sponsors shown1
Advertisement

Clinical trials

5 shown
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry INCT01040130 · 2010-01-01
COMPLETED
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IINCT01040793 · 2010-01-01
COMPLETED
12 / 48 wk Pivotal PFT vs PBO in COPD IINCT00782509 · 2009-02-01
COMPLETED
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease INCT00793624 · 2009-02-01
COMPLETED
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease IINCT00796653 · 2009-01-01
COMPLETED

Trial status mix

COMPLETED5

Phase mix

PHASE35

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.